Pharmaceutical Industry news, analysis and insights
The latest news from the global pharmaceutical industry
Bharat Biotech has recently launched its new intranasal COVID-19 vaccine iNCOVACC
The TGA has announced its approval of the use of psychedelics to treat certain mental health conditions
A strongly drug-resistant bacterium has been found in various brands of artificial tears eye drops, infecting 55 people throughout 12 states
A subsidiary of J&J has lost a bankruptcy petition aiming to transfer thousands of legal claims against the subsidiary related to the claim that its talcum powder causes cancer
WHO has issued a 'call to action' to all member states in order to try to prevent, detect and respond to incidences of illegitimate medical products
SU2C has announced four teams focusing on increasing diversity in early phase cancer clinical trials
A parliamentary committee in the Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as it has sold contaminated medicine that is believed to be linked to the deaths of at least 70 children in the Gambia.
The FDA has approved Adstiladrin (scientific name nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)- unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours.
Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company developing an investigational drug to treat human immunodeficiency virus (HIV).
Following new rules from the FDA under the Biden administration, patients can now obtain the abortion pill mifepristone from retail pharmacies, rather than having to collect the medication in person from their healthcare provider. A prescription for the drug is still required, however this can now be filled at an instore pharmacy or by mail order.
The FDA has approved new and contraversial Alzheimer’s drug, lecanemab
The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high point, which has led to multiple manufacturers reporting shortages of a flu drug, Tamiflu.